PDS Biotech Shifts Focus in Cancer Fight

PDS Biotech made a big choice this week. The company stopped developing a medicine for head and neck cancer. This drug was in its final testing stage, called phase 3.

Now, PDS Biotech will focus all its power on a different drug. This new medicine fights colon cancer that has spread. It is in an earlier testing stage, phase 2. The company sees great hope for this colon cancer treatment.

This move shows PDS Biotech wants to win its fight against colon cancer. They believe this new drug offers a better chance to help patients. Investors will watch closely to see if this new focus pays off for the company and for those who need new treatments.

Source: FierceBiotech